期刊文献+

甲型肝炎病毒Vero细胞适应株(YN5株)的传代稳定性 被引量:2

The stability of vero cell adapted HAV strain (YN5) during passage cultivation
原文传递
导出
摘要 为检验甲型肝炎病毒Vero细胞适应株(YN5株)的传代稳定性,采用连续传代的方法,进行24 d适应性培养,结果表明随着增殖代次的增加,滴度呈递增趋势,18代后滴度趋于稳定.至23代时感染性滴度达8.67LogCCID_(50)/mL,抗原滴度1:4 096.25代毒种经连续3批中试规模生产,其抗原增殖水平稳定,所制备的灭活疫苗免疫原性良好.证明HAV YN5株已适应Vero细胞,增殖稳定,为大规模生产提供了有效保障. To investigate the stability of HAV adapted strain( YN5)of Vero cell in pilot scale, serial passage was used to carry out 24 d adaptability cultivation. It showed that the titre increased progressively and tended to stable after 18 th generation. The infective titre reached 8.67 LogCCID_(50)/mL and antigen titre reached 1:4 096 at 23 rd generation. The immunogenicity of the deactivated vaccine precipitated by the virus strain of 25 th generation is fine, while antigen proliferation level was stable after continuous 3 batches of pilot scale production.It demonstrated that HAV YN5 , whose conservation and proliferation were stable, had already adapted to Vero cell ,and it ensured the large scale manufacture effectively in future.
出处 《云南大学学报(自然科学版)》 CAS CSCD 北大核心 2007年第S3期335-337,共3页 Journal of Yunnan University(Natural Sciences Edition)
基金 国家高技术研究发展专项经费资助项目(2002AA223313) 云南省科技计划资助项目(2001XY01)
关键词 HAV YN5株 VERO细胞 稳定性 HAV YN5 strain vero cell stability
  • 相关文献

参考文献7

  • 1练幼辉,胡彩珍,陶林,周彩莲,马波,鲁明.精制甲型肝炎灭活疫苗的狨猴保护实验[J].中国实验动物学报,2004,12(3):180-182. 被引量:4
  • 2陈尔佳,马波,魏绍忠.甲型肝炎病毒Vero细胞适应株的选育研究[J].微生物学免疫学进展,2003,31(4):1-4. 被引量:2
  • 3王真行,徐冰.WHO关于甲型肝炎疫苗的意见书[J].国外医学(预防.诊断.治疗用生物制品分册),2000,23(6):249-251. 被引量:4
  • 4HORNICK R,TUCKER R,KAPLAN K M,et al.A randomized study of a flexible booster dosing regimen of VAQTA in adults:safety,tolerability,and immunogenicity[ J][].Vaccine.2001
  • 5Andre FE.Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines[].Vaccine.2001
  • 6Parment PA,Emilsson H.Hepatitis A after a single dose of an inactivated hepatitis A vaccine[].Scandinavian Journal of Infectious Diseases.2002
  • 7Parment PA,Emilsson H.Hepatitis A after a single dose of an inactivated hepatitis A vaccine[].Scandinavian Journal of Infectious Diseases.2002

二级参考文献14

  • 1练幼辉,曹逸云,金炜翔,陈统球,董德祥,龙润乡.甲型肝炎减毒活疫苗(H_2株)的猴体保护试验[J].中国实验动物学杂志,1994,4(3):129-131. 被引量:3
  • 2董关木,刘增顺,俞永新,严子林,刘景华.狂犬病毒CTN-1株在Vero细胞上的适应传代研究[J].微生物学免疫学进展,1995,23(2):82-85. 被引量:20
  • 3[3]Provost PJ,Hilleman MR. Propagation of human hepatitis A virus in cell culture in vitro[J].Proc Soc Exp Biol Med,1979,160:213-221.
  • 4[4]Dong DX,Lian YH, Chen TQ, et al. The trial preparation of attenuated live hepatitis A vaccine[J]. Proc CAMS and PUMS,1998,3(4):199-202.
  • 5Bruhl P, Kerschbaum A, Kistner 0, et 8.1. Humoral and cell-mediated immunity to vero cell-derived influenza vaccine[J]. Vaccine 2000, 19(9-10) ..1149-1158.
  • 6Srivastava AK, Putnak JR, Lee SH, et 8.1. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells[J]. Vaccine 2001, 19(31) :4557-4565.
  • 7Pannent PA, Emilsson H. Hepatitis A after a single dose of an inactivated hepatitis A vaccine[J]. Scand J Infect Dis 2002,34(8):634.
  • 8Andrv FE. Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines[J]. Vaccine 2001, 12; 20(3-4): 292-293.
  • 9Homick R, Tucker R, Kaplan KM, et al. A randomized study of a flexible booster dosing regimen of VAQTA in adults: safety, tolerability, and inununogenicity[J]. Vaccine 2001, 14; 19(32) :4727-4731.
  • 10Minutello M,Zotti C, Orecchia S, et al. Dose range evaluation of a new inactivated hepatitis A vaccine administered as a single dose followed by a booster[J]. Vaccine 2000, 15; 19(1 ) :10-15.

共引文献6

同被引文献26

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部